AstraZeneca says blood-clot risk isn't increased by two doses of vaccine
AstraZeneca PLC said Wednesday that analysis of its Covid-19 vaccine Vaxzevria showed no increased incidence of thrombosis with thrombocytopenia syndrome after a second dose.
The estimated rate of thrombosis with thrombocytopenia syndrome was 2.3 for every million vaccines, with incidence rates comparable to those among unvaccinated individuals, the Cambridge, U.K.-based pharmaceutical company AZN, +1.18% AZN, +0.21% said.No specific risk factors or definitive cause have been identified in the safety data, the company said.
AstraZeneca said the data was published in the medical journal The Lancet, and that its database included reported cases of thrombosis with thrombocytopenia syndrome globally up to April 30 occurring within 14 days of administration of the first or second dose of its vaccine.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Covid-19: Health Trusts cancel surgeries as Covid admissions riseThe chief medical officer says the health service is operating under 'huge pressures'.
Leer más »
Symptomatic breakthrough COVID-19 infections rare, CDC data estimatesNationwide, approximately 153,000 symptomatic breakthrough cases are estimated to have occurred as of last week, representing approximately 0.098% of those fully vaccinated, according to unpublished internal CDC document obtained by ABC News.
Leer más »
In these 2 states, every county is listed as 'high transmission' for Covid-19Florida and Arkansas currently share a grim distinction when it comes to the spread of the coronavirus
Leer más »
Covid-19: No more deaths and 639 new cases in NINo more people have died within 28 days of testing positive for Covid-19 in Northern Ireland.
Leer más »
Some people are seeking out a second dose of Covid-19 vaccine after getting J&J shotJason Gallagher, an infectious disease pharmacist in Philadelphia had gotten the Johnson & Johnson Covid-19 vaccine through a clinical trial in November, but this summer he didn't like the direction Covid-19 cases were taking due to variants.
Leer más »